Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Immuno-Grade GLP1 Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Immunohistochemical identification of Glucagon-Like Peptide 1 Receptor in pancreas
GLP1 (IHC-grade), Glucagon-Like Peptide 1...
The GLP1 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GLP1 Receptor. The GLP1 antibody can be used to isolate and enrich GLP1 receptors from cell and tissue lysates. It also detects GLP1 in...
$ 375.00 *
Details

The glucagon-like peptide-1 receptor (GLP-1R), encoded by GLP1R, is a class B1 G protein-coupled receptor activated by GLP-1, an incretin hormone released from intestinal L cells after nutrient ingestion. It couples predominantly to Gs, stimulating adenylyl cyclase and increasing intracellular cAMP. GLP-1R is expressed on pancreatic β-cells and in selected neuronal populations involved in appetite and gastrointestinal regulation. Its activation enhances glucose-dependent insulin secretion, suppresses glucagon secretion, delays gastric emptying, and reduces food intake. Agonist stimulation promotes β-arrestin recruitment and receptor internalization, although internalization can proceed independently of β-arrestins in experimental systems. Internalized GLP-1R can sustain cAMP signaling from endosomes before recycling to the plasma membrane or undergoing lysosomal degradation. Approved agonists include exenatide, liraglutide, dulaglutide, and semaglutide for type 2 diabetes, with specific liraglutide and semaglutide formulations also approved for chronic weight management. Tirzepatide, which activates both GLP-1R and GIPR, is also approved for type 2 diabetes and chronic weight management. For more information on GLP1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003 Mar;55(1):167-94. doi: 10.1124/pr.55.1.6. PMID: 12615957.

Bataille D, Chan SL, Delagrange P, Drucker DJ, Göke B, Hills R, Mayo KE, Miller LJ, Salvatori R, Thorens B. Glucagon receptor family in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

The glucagon-like peptide-1 receptor (GLP-1R), encoded by GLP1R , is a class B1 G protein-coupled receptor activated by GLP-1, an incretin hormone released from intestinal L cells after nutrient... read more »
Close window
Immuno-Grade GLP1 Receptor Antibodies

The glucagon-like peptide-1 receptor (GLP-1R), encoded by GLP1R, is a class B1 G protein-coupled receptor activated by GLP-1, an incretin hormone released from intestinal L cells after nutrient ingestion. It couples predominantly to Gs, stimulating adenylyl cyclase and increasing intracellular cAMP. GLP-1R is expressed on pancreatic β-cells and in selected neuronal populations involved in appetite and gastrointestinal regulation. Its activation enhances glucose-dependent insulin secretion, suppresses glucagon secretion, delays gastric emptying, and reduces food intake. Agonist stimulation promotes β-arrestin recruitment and receptor internalization, although internalization can proceed independently of β-arrestins in experimental systems. Internalized GLP-1R can sustain cAMP signaling from endosomes before recycling to the plasma membrane or undergoing lysosomal degradation. Approved agonists include exenatide, liraglutide, dulaglutide, and semaglutide for type 2 diabetes, with specific liraglutide and semaglutide formulations also approved for chronic weight management. Tirzepatide, which activates both GLP-1R and GIPR, is also approved for type 2 diabetes and chronic weight management. For more information on GLP1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003 Mar;55(1):167-94. doi: 10.1124/pr.55.1.6. PMID: 12615957.

Bataille D, Chan SL, Delagrange P, Drucker DJ, Göke B, Hills R, Mayo KE, Miller LJ, Salvatori R, Thorens B. Glucagon receptor family in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023; 2023(1).

Recently viewed